Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology - Clinical Diagnosis: Solid Tumors

Incremental clinical value of a dedicated RT planning FDG PET-CT over staging PET-CT in non-small cell lung cancer

Peter Lin, Shalini Vinod, Michael Lin, Ivan HoShon and Seu Som
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 285;
Peter Lin
1Liverpool Hospital, Dept of Nuclear Medicine and PET, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shalini Vinod
2Liverpool Hospital, Dept of Rad Onc, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Lin
1Liverpool Hospital, Dept of Nuclear Medicine and PET, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan HoShon
1Liverpool Hospital, Dept of Nuclear Medicine and PET, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seu Som
1Liverpool Hospital, Dept of Nuclear Medicine and PET, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 50 no. supplement 2 285

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Peter Lin1,
  2. Shalini Vinod2,
  3. Michael Lin1,
  4. Ivan HoShon1 and
  5. Seu Som1
  1. 1Liverpool Hospital, Dept of Nuclear Medicine and PET, Sydney, Australia
  2. 2Liverpool Hospital, Dept of Rad Onc, Sydney, Australia

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: July 2015 to April 2025

AbstractFullPdf
Jul 2015100
Sep 2015400
Jan 2016200
Mar 2016100
Jul 2016100
Aug 2016100
Oct 2016200
Nov 2016200
Dec 2016200
Mar 2017300
Aug 2017200
Sep 2017100
Oct 2017200
Dec 2017100
Jan 2018400
Mar 2018200
Apr 2018200
Aug 2018100
Sep 2018300
Oct 2018200
Nov 2018100
Dec 2018200
Mar 2019100
Apr 2019100
May 2019100
Jul 2019300
Sep 2019500
Nov 2019500
Dec 2019100
Jan 2020400
Feb 2020400
Mar 20201400
Apr 20201000
Jul 2020400
Aug 20207200
Sep 202010200
Oct 20201100
Nov 20202100
Dec 20201000
Jan 2021100
Feb 20211600
Mar 20211100
Apr 20211200
May 20212000
Jun 20211200
Jul 20215500
Aug 20216700
Sep 20211000
Oct 2021900
Nov 20215300
Dec 20213300
Jan 20226700
Feb 20221800
Mar 20221200
Apr 2022700
May 20221900
Jun 2022100
Aug 2022600
Sep 2022300
Dec 2022100
Mar 2023100
Apr 2023300
May 2023100
Jun 2023200
Jul 2023100
Aug 2023200
Sep 2023100
Oct 2023300
Nov 2023100
Dec 2023300
Jan 2024300
Feb 2024200
Mar 2024300
Apr 2024100
May 2024200
Jun 2024500
Aug 2024600
Sep 2024500
Oct 2024100
Nov 2024200
Dec 2024500
Jan 2025300
Mar 2025200
Apr 2025700
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Incremental clinical value of a dedicated RT planning FDG PET-CT over staging PET-CT in non-small cell lung cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Incremental clinical value of a dedicated RT planning FDG PET-CT over staging PET-CT in non-small cell lung cancer
Peter Lin, Shalini Vinod, Michael Lin, Ivan HoShon, Seu Som
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 285;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Incremental clinical value of a dedicated RT planning FDG PET-CT over staging PET-CT in non-small cell lung cancer
Peter Lin, Shalini Vinod, Michael Lin, Ivan HoShon, Seu Som
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 285;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology - Clinical Diagnosis: Solid Tumors

  • Comparison of FLT PET and FDG PET for the evaluation of primary head and neck cancer
  • Detection and evaluation of primary gastric malignancy by gastric expansion with milk immediately before FDG PET scanning
  • Effect of oral glucose loading after standard FDG PET/CT on the detection of liver metastases
Show more Oncology - Clinical Diagnosis: Solid Tumors

Lung III

  • Role of PET/CT in evaluation of treatment response in recurrent lung cancer
  • Temporal changes of FDG uptake in post radiation pneumonitis
  • Variation of FDG-PET tumor metabolism during external radiotherapy (ERT) in patients with non small cell lung cancer (NSCLC)
Show more Lung III

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire